While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

84th Scientific Sessions supporting TERN-501 in combination with a GLP-1 receptor agonist for obesity Preclinical findings ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Perrigo intends to put focus at select retailers on over-the-counter medications that relieve the side effects of GLP-1 drugs ...

A new study found that the weight loss drug Ozempic can help reduce a stroke patient’s risk of a heart attack or death. The ...

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Novo Nordisk is working on a new obesity drug that could help ... Semaglutide, the GLP-1 drug that Novo sells under the brand ...